Array-based resequencing for mutations causing familial hypercholesterolemia

Atherosclerosis

Volumn 216, Issue 2, 2011, Pages 383-389

  Chiou, Kuan Rau ^a,c   Charng, Min Ji ^b,c   Chang, Hua Mei ^d  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d VITA GENOMICS INC   (Taiwan)

Author keywords

Array; Familial defective apolipoprotein B; Familial hypercholesterolemia; Resequence

Indexed keywords

APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN RECEPTOR; PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE DELETION; GENE INSERTION; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MUTATIONAL ANALYSIS; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST;

ADULT; APOLIPOPROTEINS B; AUTOMATION; DNA MUTATIONAL ANALYSIS; FEMALE; GENE DELETION; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREVALENCE; RECEPTORS, LDL; SERINE ENDOPEPTIDASES;

EID: 79957977001     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.02.006     Document Type: Article

References (30)

1. Rader D.J., Cohen J., Hobbs H.H. Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J Clin Invest 2003, 111(12):1795-1803.
2. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 1986, 232(4755):34-37.
3. Soria L.F., Ludwig E.H., Clarke H.R., et al. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci U S A 1989, 86(2):587-591.
4. Abifadel M., Varret M., Rabés J.P., et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 2003, 34(2):154-156.
5. Austin M.A., Hutter C.M., Zimmern R.L., Humphries S.E. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol 2004, 160(5):407-420.
6. Karaman M.W., Groshen S., Lee C.C., Pike B.L., Hacia J.G. Comparisons of substitution, insertion and deletion probes for resequencing and mutational analysis using oligonucleotide microarrays. Nucleic Acids Res 2005, 33(3):e33.
7. Kothiyal P., Cox S., Ebert J., et al. An overview of custom array sequencing. Curr Protoc Hum Genet 2009, [Chapter 7:Unit 7.17].
8. Bruce C.K., Smith M., Rahman F., et al. Design and validation of a metabolic disorder resequencing microarray (BRUM1). Hum Mutat 2010, 31(7):858-865.
9. Humphries S.E., Whittall R.A., Hubbart C.S., et al. Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk. J Med Genet 2006, 43(12):943-949.
10. Charng M.J., Chiou K.R., Chang H.M., et al. Identification and characterization of novel low-density lipoprotein receptor mutations of familial hypercholesterolaemia patients in Taiwan. Eur J Clin Invest 2006, 36(12):866-874.
11. Cutler D.J., Zwick M.E., Carrasquillo M.M., et al. High-throughput variation detection and genotyping using microarrays. Genome Res 2001, 11(11):1913-1925.
12. Schouten J.P., McElgunn C.J., Waaijer R., et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002, 30(12):e57.
13. Mandal M.N., Heckenlively J.R., Burch T., et al. Sequencing arrays for screening multiple genes associated with early-onset human retinal degenerations on a high-throughput platform. Invest Ophthalmol Vis Sci 2005, 46(9):3355-3362.
14. Liu C., Aronow B.J., Jegga A.G., et al. Novel resequencing chip customized to diagnose mutations in patients with inherited syndromes of intrahepatic cholestasis. Gastroenterology 2007, 132(1):119-126.
15. Fokstuen S., Lyle R., Munoz A., et al. A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy. Hum Mutat 2008, 29(6):879-885.
16. Waldmüller S., Müller M., Rackebrandt K., et al. Array-based resequencing assay for mutations causing hypertrophic cardiomyopathy. Clin Chem 2008, 54(4):682-687.
17. Takahashi Y., Seki N., Ishiura H., et al. Development of a high-throughput microarray-based resequencing system for neurological disorders and its application to molecular genetics of amyotrophic lateral sclerosis. Arch Neurol 2008, 65(10):1326-1332.
18. Denning L., Anderson J.A., Davis R., et al. High throughput genetic analysis of congenital myasthenic syndromes using resequencing microarrays. PLoS One 2007, 2(9):e918.
19. Hoischen A., Gilissen C., Arts P., et al. Massively parallel sequencing of ataxia genes after array-based enrichment. Hum Mutat 2010, 31(4):494-499.
20. Graham I., Atar D., Borch-Johnsen K., et al. ESC committee for practice guidelines. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Atherosclerosis 2007, 194(1):1-45.
21. Fouchier S.W., Kastelein J.J., Defesche J.C. Update of the molecular basis of familial hypercholesterolemia in The Netherlands. Hum Mutat 2005, 26(6):550-556.
22. Tejedor D., Castillo S., Mozas P., et al. Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia. Clin Chem 2005, 51(7):1137-1144.
23. Alonso R., Defesche J.C., Tejedor D., et al. Genetic diagnosis of familial hypercholesterolemia using a DNA-array based platform. Clin Biochem 2009, 42(9):899-903.
24. Taylor A., Wang D., Patel K., et al. Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project. Clin Genet 2010, 77(6):572-580.
25. Wright W.T., Heggarty S.V., Young I.S., et al. Multiplex MassARRAY spectrometry (iPLEX) produces a fast and economical test for 56 familial hypercholesterolaemia-causing mutations. Clin Genet 2008, 74(5):463-468.
26. Blesa S., Garcia-Garcia A.B., Martinez-Hervas S., et al. Analysis of sequence variations in the LDL receptor gene in Spain: general gene screening or search for specific alterations?. Clin Chem 2006, 52(6):1021-1025.
27. Tejedor D., Castillo S., Mozas P., et al. Comparison of DNA array platform vs DNA sequencing as genetic diagnosis tools for familial hypercholesterolemia. Clin Chem 2006, 52(10):1971-1972.
28. Defesche J. World health organisation report on familial hypercholesterolemia. Atherosclerosis 2001, 154(1):242.
29. Marks D., Thorogood M., Neil H.A., Humphries S.E. A review on the diagnosis, natural history, and treatment of familial hypercholesterolemia. Atherosclerosis 2003, 168(1):1-14.
30. Damgaard D., Larsen M.L., Nissen P.H., et al. The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population. Atherosclerosis 2005, 180(1):155-160.